Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05447156
Other study ID # SPH-2022-30604
Secondary ID MCC CPRC
Status Completed
Phase N/A
First received
Last updated
Start date December 14, 2022
Est. completion date November 29, 2023

Study information

Verified date February 2024
Source Masonic Cancer Center, University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim 2: To assess the preliminary feasibility and acceptability of a tailored smoking cessation app prototype (here forward called tailored QuitGuide) among American Indian (AI) smokers. Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 29, 2023
Est. primary completion date September 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - American Indian person based on self-report - Age = 18 years - Interested in quitting smoking - Smoke = 3 commercial tobacco cigarette per day (CPD) in the past 30 days o Use of other commercial tobacco products (e.g., e-cigarettes) is permitted if they report cigarettes being their primary product - Smartphone ownership with the ability to download applications and sufficient data to complete research procedures Exclusion Criteria: - Aim 2 • Does not speak or read English - Aim 3 - Participation in Aim 2 - New or change in pharmacotherapy for smoking cessation (includes: nicotine gum, patch, lozenge, inhaler OR medications Chantix/Wellbtrutin/Zyban/Bupropion) in past month - Does not speak or read English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored QuitGuide app
This is an app not available to the public. It was developed/tailored based on an app available to the public and can be downloaded.
Standard QuitGuide app
This is an app available to the public.

Locations

Country Name City State
United States Masonic Cancer Center - University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Masonic Cancer Center, University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of app use The number of times the app is initiated per day will be measured using data from Smokefree.gov. If a participant does not use the app on a particular day, Smokefree.gov records this as non-use or 0 for that day. The total number of times will be summarized for analysis by totaling the number of times the app is initiated from randomization to 5 weeks post-randomization. 2 weeks post enrollment for aim 2 and 5 weeks post enrollment for aim 3
Secondary Frequency of app use The number of times the app is initiated per day will be measured using data from Smokefree.gov. If a participant does not use the app on a particular day, Smokefree.gov records this as non-use or 0 for that day. The total number of times will be summarized for analysis by totaling the number of times the app is initiated from randomization to 5 weeks post-randomization. 1 week post-randomization for aim 3/ Not applicable for aim 2
Secondary Frequency of interactions with various app features (e.g. quit tips, trigger list) over the 5 weeks The number of times the app is initiated per day will be measured using data from Smokefree.gov. If a participant does not use the app on a particular day, Smokefree.gov records this as non-use or 0 for that day. The total number of times will be summarized for analysis by totaling the number of times the app is initiated from randomization to 5 weeks post-randomization. 2 weeks post enrollment for aim 2 and 5 weeks post enrollment for aim 3
Secondary Study attrition measured as percentage of randomized participants that complete the final phone interview at 5 weeks Percentage of randomized participants that complete the final phone interview at 5 weeks 5 weeks post enrollment aim 3
Secondary Frequency of returning saliva sample by 2 weeks post the week 5 interview Count of randomized participants that return saliva sample 2 weeks after the 5 weeks post enrollment (end of intervention) 5 weeks post enrollment aim 3
Secondary Usability of App Design measured using System Usability scale (SUS) Scores for each question (1-5) are added together for an overall score and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100 and presented as percentile rankings. Mean and standard deviations or medians and ranges of percentile rankings will be calculated. 5 weeks post enrollment
Secondary Acceptability of overall app Mean and standard deviations or medians and ranges of Likert-scale responses to questions such as 'How likely would you be to recommend the app to a friend?' and 'Would you be interested in using the app in the future if needed?' 5 weeks post enrollment
Secondary Fit of app with culture Mean and standard deviations or medians and ranges of Likert-scale responses to questions such as 'The app fits my American Indian culture such as its history, traditions, and customs' and ' The app makes me feel more connected to my American Indian culture such as its history, traditions, and customs.' 5 weeks post enrollment
See also
  Status Clinical Trial Phase
Withdrawn NCT02432066 - Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions Phase 2
Completed NCT03960138 - Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Completed NCT04646668 - Comparative Abuse Liability Among African American and White Smokers N/A
Completed NCT02560324 - Effect of Ramelteon on Smoking Abstinence Phase 2
Completed NCT02347605 - Medicinal Nicotine for Preventing Cue Induced Craving N/A
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Terminated NCT01800500 - Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers N/A
Completed NCT01625767 - Tobacco Approach Avoidance Training for Adolescent Smokers-1 Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01428310 - Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Phase 1
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT01337817 - A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers Phase 1
Completed NCT00967005 - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers Phase 2
Active, not recruiting NCT00751660 - Screening Methods in Finding Lung Cancer Early in Current or Former Smokers N/A
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00664261 - Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking N/A
Completed NCT00218179 - Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 N/A
Completed NCT00158145 - Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2 Phase 2
Completed NCT01213524 - Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia Phase 2